Stock ACLX ARCELLX, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Arcellx, Inc.

Equities

ACLX

US03940C1009

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-30 pm EDT 		5-day change 1st Jan Change
50.02 USD -2.13% Intraday chart for Arcellx, Inc. -8.12% -9.87%
Apr. 18 Arcellx Insider Sold Shares Worth $522,260, According to a Recent SEC Filing MT
Apr. 03 Arcellx Insider Sold Shares Worth $1,548,887, According to a Recent SEC Filing MT

Evolution of the average Target Price on Arcellx, Inc.

Price target over the last 5 years

History of analyst recommendation changes

f492d998.hxgk457nbX1cTVu0-GmUltpO8TD2_nlPksd3slBPOtY.tllFkMeILho2ORrtuhP4xo0UwB3GnUsZ3rI97WJ5SLTIUx2m9IsDODIdYw~a7fdde50a51c6923493130af455a9e32

Analyst Recommendations on Arcellx, Inc.

Arcellx Insider Sold Shares Worth $522,260, According to a Recent SEC Filing MT
Arcellx Insider Sold Shares Worth $1,548,887, According to a Recent SEC Filing MT
Arcellx Insider Sold Shares Worth $35,575,755, According to a Recent SEC Filing MT
Needham Raises Arcellx Price Target to $81 From $72, Maintains Buy Rating MT
Morgan Stanley Initiates Arcellx With Overweight Rating, $81 Price Target MT
Truist Adjusts Price Target on Arcellx to $87 From $57, Maintains Buy Rating MT
Barclays Adjusts Arcellx's Price Target to $73 From $62, Keeps Overweight Rating MT
Scotiabank Starts Arcellx With Sector Outperform Rating, $66 Price Target MT
Needham Adjusts Price Target on Arcellx to $65 From $60, Keeps Buy Rating MT
Arcellx Phase 1 Expansion Study Data for Cancer Candidate Shows 100% Overall Response Rate MT
HC Wainwright Raises Arcellx's Price Target to $60 From $50, Keeps Buy Rating MT
Needham Raises Arcellx Price Target to $60 From $51, Maintains Buy Rating MT
TD Cowen Starts Arcellx at Outperform MT
UBS Initiates Coverage on Arcellx With Buy Rating, $52 Price Target MT
Stifel Trims Price Target on Arcellx to $52 From $54, Maintains Buy Rating MT
Baird Adjusts Price Target on Arcellx to $52 From $40, Maintains Outperform Rating MT
Needham Reinstates Buy Rating on Arcellx With $51 Price Target MT
HC Wainwright Adjusts Arcellx's Price Target to $50 From $49, Keeps Buy Rating MT
Truist Securities Trims Price Target on Arcellx to $57 From $60, Maintains Buy Rating MT
Small Rate Cut in China Weighs on Wall Street Pre-Bell; Asia Mixed, Europe Off MT
Truist Securities Starts Arcellx at Buy With $60 Price Target MT
BofA Securities Adjusts Arcellx's Price Target to $50 From $39, Keeps Buy Rating MT
HC Wainwright Adjusts Price Target on Arcellx to $49 From $40, Keeps Buy Rating MT
Barclays Adjusts Price Target on Arcellx to $49 From $38, Keeps Overweight Rating MT
Canaccord Genuity Adjusts Arcellx's Price Target to $49 From $40, Keeps Buy Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
15
Last Close Price
50.02 USD
Average target price
80.31 USD
Spread / Average Target
+60.55%
High Price Target
87 USD
Spread / Highest target
+73.93%
Low Price Target
73 USD
Spread / Lowest Target
+45.94%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Arcellx, Inc.

Needham & Co.
Morgan Stanley
Truist Securities
Barclays
Scotiabank
HC Wainwright
TD Cowen
UBS
Baird
Stifel Nicolaus
BofA Securities
Canaccord Genuity
Guggenheim
SVB Securities LLC
SVB Leerink
William Blair & Co.

Ratings for Arcellx, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. ACLX Stock
  4. Consensus Arcellx, Inc.